Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07122414
What this trial is testing

Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd 80
Not applicableLooking for participantsNCT07088536
What this trial is testing

Occupational Situation and Return to Work of Urological Patients

Who this might be right for
Bladder CancerProstate CancerRenal Cancer+1 more
Jagiellonian University 2,000
Testing effectiveness (Phase 2)Study completedNCT00661609
What this trial is testing

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more
AstraZeneca 54
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)Study completedNCT01191892
What this trial is testing

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUreter Cancer+1 more
Cardiff University 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Not applicableEnded earlyNCT05568407
What this trial is testing

Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Who this might be right for
Bladder Cancer
Pfizer 19
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Large-scale testing (Phase 3)Active Not RecruitingNCT05092958
What this trial is testing

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Who this might be right for
Advanced Bladder Urothelial CarcinomaAdvanced Renal Pelvis Urothelial CarcinomaAdvanced Ureter Urothelial Carcinoma+15 more
National Cancer Institute (NCI) 654
Not applicableUnknownNCT05139134
What this trial is testing

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Who this might be right for
Urinary Bladder Urothelial Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)WithdrawnNCT00386516
What this trial is testing

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Who this might be right for
Cancer of the Bile DuctGallbladder Cancer
Galectin Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT01261728
What this trial is testing

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT07198451
What this trial is testing

Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial

Who this might be right for
Non Muscle Invasive Bladder Cancer
Shanghai University of Traditional Chinese Medicine 320
Not applicableUnknownNCT06245759
What this trial is testing

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

Who this might be right for
Non-Muscle-Invasive Bladder CancerBladder Cancer
Huazhong University of Science and Technology 120,000
Testing effectiveness (Phase 2)UnknownNCT05016973
What this trial is testing

A Clinical Study of RC48-ADC Combined With Triplizumab For Treatment of Myometrial Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 25
Testing effectiveness (Phase 2)Study completedNCT00585689
What this trial is testing

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
University of Michigan Rogel Cancer Center 29
Not applicableUnknownNCT05429710
What this trial is testing

SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

Who this might be right for
Urinary Bladder Neoplasm
Sohag University 60
Early research (Phase 1)Study completedNCT00002949
What this trial is testing

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Who this might be right for
Bladder CancerCervical CancerEndometrial Cancer+1 more
University of Chicago 33
Testing effectiveness (Phase 2)Study completedNCT00722553
What this trial is testing

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Who this might be right for
Carcinoma, Transitional CellBladder CancerBladder Neoplasm
Acrotech Biopharma Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Next Page